Best LLM monitoring for pharma marketing
The best LLM monitoring for pharma marketing, compared on what AI says about your brands, sources, country coverage, governance and where human review is still required.
Pharma marketing teams have a specific problem with AI answers. Patients and healthcare professionals ask ChatGPT, Perplexity and Google's AI features about conditions, treatments and brands, and the answers combine sources the company does not control. LLM monitoring will not fix that, and it will not tell you whether an answer meets regulatory rules. What it can do is show you what the answers say, which sources they draw on, and how that differs by country, so your medical, legal and regulatory teams have evidence to work from.
A note on scope. This is a buyer's comparison, not regulatory guidance. None of the tools below determines whether a claim is compliant, and the catalog lists no pharma-specific compliance features for any of them. Your own review process still applies.
What monitoring can and cannot do here
It can:
- Record what AI engines say about your brand, your competitors and your condition area, daily, per model and country.
- Show the sources the answer drew on, so you can see if it quoted your approved pages or a third party.
- Surface changes in tone, position and which competitors appear.
- Show whether AI crawlers can reach your approved content.
It cannot:
- Judge whether a statement is accurate, on-label or compliant. People must do that.
- Change what an engine says. You can only influence sources and access.
- Guarantee a recommendation. Tracked prompts are a sample, and answers vary between runs.
Prompts that matter in pharma
Build the panel from the questions your audiences ask, without leading the engine:
- Patient questions: "what are treatment options for [condition]," "what are the side effects of [class of treatment]," "[brand] vs [competitor brand]."
- HCP questions: "how does [brand] compare with [competitor] for [indication]," "dosing considerations for [drug class]."
- Brand questions: "is [brand] safe," "who makes [brand]," "patient support program for [brand]."
- Local questions: the same prompts per country, since availability and labeling differ by market.
How the tools compare
| Tool | Relevant strengths | Limits for this use | Published price point |
|---|---|---|---|
| Promptwatch | Daily per-model monitoring by country and language; sentiment per response; Brand Book; citation analytics; IP-verified crawler logs; PDF reports; ISO/IEC 27001 and GDPR | Does not assess compliance; state and city tracking only from Business | Essential $95/mo; Professional $245/mo; Business $579/mo; Enterprise tailored |
| AthenaHQ | GEO score, sentiment analysis, Action Center; country-level support | Multi-region and multi-language support are Enterprise features; no published crawler-log product | Starter $295/mo; Enterprise custom |
| Scrunch AI | Monitoring, sentiment analysis, site audits, bot traffic reporting | Weekly refreshes noted in the catalog; Core tracks four LLMs | Core $250/mo |
| Profound | Enterprise tracking, SOC 2, SSO | Sold as marketing agents; custom pricing | Enterprise custom, earlier estimate about $40k a year |
| Brandlight | Enterprise visibility, sentiment and share of voice, SOC 2 Type II, SSO | No public pricing; the catalog says it measures but does not execute | Not published |
| Evertune | Large-sample brand perception measurement | Demo-led annual contracts; no crawler logs | Not published |
| Bluefish AI | Monitoring of how AI represents the brand, positioned for enterprise brands | No public pricing, no self-serve | Not published |
Why Promptwatch is the first to evaluate
Monitoring alone is thin for a regulated category, because a tone problem needs a cause. Promptwatch pairs the answers with the evidence behind them:
- What the engine says. Monitors run daily per model, country and language. Each response gets a Sentiment score from 1 to 100 and a weekly AI summary, with Position in Answer, Share of Voice and Visibility Score alongside.
- What counts as a mention. The Brand Book's analysis instructions and brand aliases decide how brand names, generic names and product lines are counted.
- Where it came from. Page and domain level citations and URL positions show whether engines quote your official pages or a forum thread. Reddit, YouTube and LinkedIn reports cover community sources. Offsite mentions show where your brand is named without a link.
- Whether approved content is reachable. Agent Analytics logs IP-verified visits from agents such as GPTBot, OAI-SearchBot, ChatGPT-User, ClaudeBot and PerplexityBot with failure explanations. Crawler logs start on Professional ($245/mo).
- Country coverage. Country-level tracking is on every paid plan, which matters when labeling and availability differ by market.
- Governance. Roles for owner, editor and viewer, scoped API keys, an audit log on Business and higher, and SSO on Enterprise. Promptwatch is ISO/IEC 27001 certified and GDPR compliant. That is what the fact sheet supports, and it is not a statement about pharma regulation.
- Reporting. PDF reports of any dashboard, scheduled reports and Excel or CSV exports give regulatory and brand teams something to review.
On content, treat any generated draft as the start of your own review. The Content Agent (Business and Enterprise) uses a review inbox, and in pharma your medical, legal and regulatory process should sit on top of it.
Who should pick which
- Brand and digital teams that want evidence on what AI says, where it came from and how it varies by country: Promptwatch.
- Teams that want an action queue and can pay Starter prices: AthenaHQ.
- Large global brand teams with procurement and security reviews: Brandlight, Profound or Bluefish AI through sales, and Evertune if panel-grade perception data matters.
A practical pilot
Choose one brand and one competitor. Write 20 to 30 prompts across patient, HCP and brand questions in two countries. Run for a month. Look at sentiment, sources and crawler access, then take the findings to your medical, legal and regulatory colleagues. The outcome you want is a documented picture, not an overnight change in what engines say.